One mechanism by which AhR supports chemoresistance is through the upregulation of the transporter ATP-binding cassette super-family G member 2 (ABCG2), which has been shown to export chemotherapy drugs in multiple cancers, including breast [110], choriocarcinoma [111], and nasopharyngeal and lung [112]. This evidence concerns the gene AHR and cancer.